CY1111588T1 - Υποκατεστημενα καρβοξαμιδια ως ανταγωνιστες μεταβολοτροπου υποδοχεα ομαδας ι - Google Patents
Υποκατεστημενα καρβοξαμιδια ως ανταγωνιστες μεταβολοτροπου υποδοχεα ομαδας ιInfo
- Publication number
- CY1111588T1 CY1111588T1 CY20111100600T CY111100600T CY1111588T1 CY 1111588 T1 CY1111588 T1 CY 1111588T1 CY 20111100600 T CY20111100600 T CY 20111100600T CY 111100600 T CY111100600 T CY 111100600T CY 1111588 T1 CY1111588 T1 CY 1111588T1
- Authority
- CY
- Cyprus
- Prior art keywords
- concentrators
- converter
- substituted carboxamides
- substituted
- carboxamides
- Prior art date
Links
- 150000003857 carboxamides Chemical class 0.000 title 1
- -1 carboxamide compound Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Η παρούσα αίτηση αναφέρεται σε μια ένωση υποκατεστημένου καρβοξαμιδίου του τύπου Ι, ή σε ένα φαρμακευτικώς αποδεκτό άλας αυτής, όπως ορίζεται εδώ, σε μια φαρμακευτική σύνθεση αυτής, και στη χρησιμοποίησή της στη θεραπεία του πόνου.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81183906P | 2006-06-08 | 2006-06-08 | |
| EP07873705A EP2076502B1 (en) | 2006-06-08 | 2007-06-07 | Substituted carboxamides as group i metabotropic receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1111588T1 true CY1111588T1 (el) | 2015-10-07 |
Family
ID=39673278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20111100600T CY1111588T1 (el) | 2006-06-08 | 2011-06-24 | Υποκατεστημενα καρβοξαμιδια ως ανταγωνιστες μεταβολοτροπου υποδοχεα ομαδας ι |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US7960419B2 (el) |
| EP (1) | EP2076502B1 (el) |
| JP (1) | JP5108878B2 (el) |
| KR (1) | KR101051559B1 (el) |
| CN (1) | CN101466691B (el) |
| AT (1) | ATE509921T1 (el) |
| AU (1) | AU2007347428B2 (el) |
| BR (1) | BRPI0712862A2 (el) |
| CA (1) | CA2652074C (el) |
| CR (1) | CR10410A (el) |
| CY (1) | CY1111588T1 (el) |
| DK (1) | DK2076502T3 (el) |
| EA (1) | EA014233B1 (el) |
| EC (1) | ECSP088939A (el) |
| ES (1) | ES2362949T3 (el) |
| HK (1) | HK1131984A1 (el) |
| HR (1) | HRP20110436T1 (el) |
| IL (1) | IL195632A (el) |
| MA (1) | MA30620B1 (el) |
| MX (1) | MX2008015485A (el) |
| MY (1) | MY148084A (el) |
| NO (1) | NO341474B1 (el) |
| NZ (1) | NZ573352A (el) |
| PL (1) | PL2076502T3 (el) |
| PT (1) | PT2076502E (el) |
| RS (1) | RS51818B (el) |
| SI (1) | SI2076502T1 (el) |
| TN (1) | TNSN08506A1 (el) |
| UA (1) | UA95480C2 (el) |
| WO (1) | WO2008103185A2 (el) |
| ZA (1) | ZA200809111B (el) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0804685D0 (en) | 2008-03-13 | 2008-04-16 | Univ Edinburgh | Therapeutic compounds and their use |
| EA018001B1 (ru) | 2008-04-04 | 2013-04-30 | Эли Лилли Энд Компани | 3-индазолил-4-пиридилизотиазолы |
| EP2443113A1 (en) * | 2009-06-15 | 2012-04-25 | The University Of Edinburgh | Amido-isothiazole compounds and their use as inhibitors of 11beta-hsd1 for the treatment of metabolic syndrome and related disorders |
| KR101702159B1 (ko) | 2009-09-16 | 2017-02-02 | 더 유니버시티 오브 에든버러 | （４―페닐―피페리딘―1―일）―［５―（1ｈ―피라졸―４―일）―티오펜―３―일］―메탄온 화합물 및 그의 용도 |
| JP5899202B2 (ja) | 2010-04-29 | 2016-04-06 | ザ ユニバーシティ オブ エディンバラ | １１β−ＨＳＤ１の阻害剤としての３，３−二置換−（８−アザ−ビシクロ［３．２．１］オクタ−８−イル）−［５−（１Ｈ−ピラゾール−４−イル）−チオフェン−３−イル］−メタノン類 |
| CN104768944B (zh) | 2012-11-13 | 2017-03-29 | 日产化学工业株式会社 | 2‑吡啶酮化合物 |
| BR112019005795A2 (pt) | 2016-09-23 | 2019-06-18 | Bayer Ag | tienouracilas n3-ciclicamente substituídas e uso das mesmas |
| CN117567266B (zh) * | 2023-11-07 | 2024-06-14 | 康龙化成手性医药技术(宁波)有限公司 | 一种制备2-甲基环丙羧酸的方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL72091A0 (en) | 1983-06-20 | 1984-10-31 | Lilly Co Eli | N'-substituted(3-aryl 5-isothiazolyl)urea derivatives |
| DE4328425A1 (de) | 1993-08-24 | 1995-03-02 | Basf Ag | Acylamino-substituierte Isoxazol- bzw. Isothiazolderivate, Verfahren zu deren Herstellung und ihre Verwendung |
| DK124393D0 (da) | 1993-11-03 | 1993-11-03 | Lundbeck & Co As H | Compounds |
| DE19542372A1 (de) * | 1995-11-14 | 1997-05-15 | Bayer Ag | Acylierte 5-Aminoisothiazole |
| UA60365C2 (uk) * | 1998-06-04 | 2003-10-15 | Пфайзер Продактс Інк. | Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця |
| JP3411262B2 (ja) * | 1999-08-20 | 2003-05-26 | 萬有製薬株式会社 | 新規スピロ化合物 |
| IL159926A0 (en) * | 2001-08-06 | 2004-06-20 | Pharmacia Italia Spa | Aminoisoxazole derivatives active as kinase inhibitors |
| US20060281803A1 (en) * | 2003-09-23 | 2006-12-14 | Lindsley Craig W | Pyrazole modulators of metabotropic glutamate receptors |
| CN1984899B (zh) * | 2004-05-12 | 2011-07-27 | 先灵公司 | Cxcr1和cxcr2趋化因子拮抗剂 |
| CA2581657A1 (en) * | 2004-09-23 | 2006-03-30 | Pfizer Products Inc. | Thrombopoietin receptor agonists |
-
2007
- 2007-06-07 AT AT07873705T patent/ATE509921T1/de active
- 2007-06-07 MY MYPI20084973A patent/MY148084A/en unknown
- 2007-06-07 EA EA200870516A patent/EA014233B1/ru not_active IP Right Cessation
- 2007-06-07 AU AU2007347428A patent/AU2007347428B2/en not_active Ceased
- 2007-06-07 UA UAA200813907A patent/UA95480C2/uk unknown
- 2007-06-07 NZ NZ573352A patent/NZ573352A/en not_active IP Right Cessation
- 2007-06-07 US US12/300,415 patent/US7960419B2/en active Active
- 2007-06-07 RS RS20110336A patent/RS51818B/en unknown
- 2007-06-07 PT PT07873705T patent/PT2076502E/pt unknown
- 2007-06-07 SI SI200730695T patent/SI2076502T1/sl unknown
- 2007-06-07 CA CA2652074A patent/CA2652074C/en not_active Expired - Fee Related
- 2007-06-07 ES ES07873705T patent/ES2362949T3/es active Active
- 2007-06-07 DK DK07873705.3T patent/DK2076502T3/da active
- 2007-06-07 BR BRPI0712862-2A patent/BRPI0712862A2/pt not_active IP Right Cessation
- 2007-06-07 JP JP2009514523A patent/JP5108878B2/ja not_active Expired - Fee Related
- 2007-06-07 CN CN2007800211890A patent/CN101466691B/zh not_active Expired - Fee Related
- 2007-06-07 EP EP07873705A patent/EP2076502B1/en active Active
- 2007-06-07 WO PCT/US2007/070572 patent/WO2008103185A2/en active Application Filing
- 2007-06-07 KR KR1020087029772A patent/KR101051559B1/ko not_active Expired - Fee Related
- 2007-06-07 PL PL07873705T patent/PL2076502T3/pl unknown
- 2007-06-07 MX MX2008015485A patent/MX2008015485A/es active IP Right Grant
- 2007-10-29 CR CR10410A patent/CR10410A/es unknown
-
2008
- 2008-10-23 ZA ZA200809111A patent/ZA200809111B/xx unknown
- 2008-12-01 IL IL195632A patent/IL195632A/en not_active IP Right Cessation
- 2008-12-02 NO NO20085028A patent/NO341474B1/no not_active IP Right Cessation
- 2008-12-03 EC EC2008008939A patent/ECSP088939A/es unknown
- 2008-12-05 TN TNP2008000506A patent/TNSN08506A1/en unknown
-
2009
- 2009-01-06 MA MA31553A patent/MA30620B1/fr unknown
- 2009-12-02 HK HK09111272.7A patent/HK1131984A1/xx not_active IP Right Cessation
-
2011
- 2011-06-09 HR HR20110436T patent/HRP20110436T1/hr unknown
- 2011-06-24 CY CY20111100600T patent/CY1111588T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1111588T1 (el) | Υποκατεστημενα καρβοξαμιδια ως ανταγωνιστες μεταβολοτροπου υποδοχεα ομαδας ι | |
| EA201071038A1 (ru) | Производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40 | |
| EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
| EA201001669A1 (ru) | Замещенные пиримидин-5-карбоксамиды 281 | |
| EA201070544A1 (ru) | Новый класс терапевтических веществ, усиливающих диффузию низкомолекулярных соединений | |
| EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
| DE602008000754D1 (de) | Tropanverbindungen | |
| MY146662A (en) | Novel n-(8-heteroaryltetrahydronaphtalene-2yl) or n-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain | |
| MA32544B1 (fr) | Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique | |
| CY1109743T1 (el) | Παραγωγα των 2-βενζοϋλο-ιμιδαζοπυριδινων, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη | |
| UA106600C2 (uk) | Карбоксамідні сполуки і способи їхнього застосування | |
| EA201000391A1 (ru) | Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция | |
| ATE440833T1 (de) | Antithrombotische diamide | |
| NO20085317L (no) | Imidazoazepinonforbindelser | |
| FR2943537B1 (fr) | Traitement des nevrites vestibulaires par l'acetyl-l-leucine | |
| UA112418C2 (uk) | Терапевтичний болезаспокійливий засіб | |
| ATE474574T1 (de) | Imidazoazephinonverbindungen | |
| MX2010008586A (es) | Amidas de acido 3-(4-fluorofenil)-3-hidroxi-2-amino-propionico y compuestos relacionados que tienen actividad analgesica. | |
| MX2013002485A (es) | Fenilacetamidas y fenilpropanamidas sustituidas y su uso. | |
| EA200802000A1 (ru) | Фармацевтически приемлемые соли и полиморфные формы | |
| DOP2008000064A (es) | Carboxamidas sustituidas. | |
| UA103767C2 (ru) | Карбоксамидные соединения для лечения метаболических расстройств | |
| EA200701086A1 (ru) | Производные изоксазола, их фармацевтические композиции и способ лечения невропатической боли |